- Home
- CMP vs MDXG Comparison
CMP vs MDXG Comparison
Compare CMP & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CMP | MDXG |
|---|---|---|
| Founded | 1993 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Metals and Minerals | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.0B |
| IPO Year | 2003 | 2007 |
Fundamental Metrics
Financial Performance| Metric | CMP | MDXG |
|---|---|---|
| Price | $23.29 | $4.44 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 5 |
| Target Price | ★ $21.50 | $10.00 |
| AVG Volume (30 Days) | 399.1K | ★ 748.2K |
| Earning Date | 05-11-2026 | 05-22-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 14.29 |
| EPS | ★ 0.43 | 0.32 |
| Revenue | N/A | ★ $418,630,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1.85 | $13.14 |
| P/E Ratio | $54.42 | ★ $14.08 |
| Revenue Growth | N/A | ★ 19.99 |
| 52 Week Low | $8.60 | $4.48 |
| 52 Week High | $27.00 | $8.20 |
Technical Indicators
Market Signals| Indicator | CMP | MDXG |
|---|---|---|
| Relative Strength Index (RSI) | 46.89 | 23.85 |
| Support Level | $17.24 | N/A |
| Resistance Level | $26.40 | $5.38 |
| Average True Range (ATR) | 1.17 | 0.19 |
| MACD | -0.15 | -0.04 |
| Stochastic Oscillator | 33.29 | 6.91 |
Price Performance
Historical ComparisonAbout CMP Compass Minerals Intl Inc
Compass Minerals currently produces two primary products: salt and specialty potash fertilizer. The company's main assets include rock salt mines in Ontario, Louisiana, and the United Kingdom. The fertilizer is produced from a brine operation at the Great Salt Lake in Utah that produces sulfate of potash and magnesium chloride. Compass' salt products are used for deicing and also by industrial and consumer end markets. The firm's sulfate of potash is used by growers of high-value crops that are sensitive to standard potash.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.